40885_2021_177_MOESM1_ESM.docx (317.92 kB)
Additional file 1 of Real-world evidence on the strategy of olmesartan-based triple single-pill combination in Korean hypertensive patients: a prospective, multicenter, observational study (RESOLVE-PRO)
journal contribution
posted on 2021-11-01, 04:19 authored by Il Suk Sohn, Sang-Hyun Ihm, Gee Hee Kim, Sang Min Park, Bum-Kee Hong, Chang Hoon Lee, Sang Hyun Lee, Dae-Il Chang, Sung-Pil Joo, Sang-Chan Lee, Yong-ho Lee, Dong Woon Jeon, Kyung Tae Jung, Si Jae Rhee, Yoon-Jin Cho, Chong-Jin KimAdditional file 1: Supplementary Figure 1. Time course change in the mean SPB/DBP at month 3, 6, 9 and 12 in patients treated only with OM/AML/HCTZ. Supplementary Table 1. Changes from baseline in the mean SBP/DBP at month 3, 6, 9 and 12 in patients with risk factors. Supplementary Table 2. Changes from baseline in the mean SBP/DBP at month 3, 6, 9 and 12 in patients with different age groups. Supplementary Table 3. Participating institutions.
